| US 7,538,125 B2 | ||
| Pharmaceutical composition | ||
| Hitoshi Ikeda, Osaka (Japan); Takashi Sohda, Osaka (Japan); and Hiroyuki Odaka, Hyogo (Japan) | ||
| Assigned to Takeda Pharmaceutical Company Limited, Osaka (Japan) | ||
| Filed on Sep. 20, 2006, as Appl. No. 11/523,771. | ||
| Application 10/937494 is a division of application No. 10/462793, filed on Jun. 17, 2003, granted, now 6,911,459. | ||
| Application 10/462793 is a division of application No. 10/095453, filed on Mar. 13, 2002, granted, now 6,599,923. | ||
| Application 10/095453 is a division of application No. 09/973689, filed on Oct. 11, 2001, granted, now 6,384,062. | ||
| Application 09/973689 is a division of application No. 09/453521, filed on Dec. 03, 1999, granted, now 6,329,404. | ||
| Application 09/453521 is a division of application No. 09/280710, filed on Mar. 30, 1999, granted, now 6,150,383. | ||
| Application 09/280710 is a division of application No. 09/057465, filed on Apr. 09, 1998, granted, now 5,965,584. | ||
| Application 09/057465 is a division of application No. 08/667979, filed on Jun. 19, 1996, granted, now 5,952,356. | ||
| Application 11/523771 is a continuation of application No. 10/937494, filed on Sep. 10, 2004, granted, now 7,144,900. | ||
| Claims priority of application No. 1995-153500 (JP), filed on Jun. 20, 1995. | ||
| Prior Publication US 2007/0203198 A1, Aug. 30, 2007 | ||
| This patent is subject to a terminal disclaimer. | ||
| Int. Cl. C07D 401/02 (2006.01); A61K 31/44 (2006.01) | ||
| U.S. Cl. 514—342 [546/269.7] | 10 Claims |
| 1. A pharmaceutical composition which comprises:
1) pioglitazone or a pharmacologically acceptable salt thereof;
2) glimepiride; and
3) a physiologically acceptable carrier.
|